GILEAD SCIENCES, INC. (GILD) — Company Profile

GILD Market Snapshot

IPODUDE.COM

$0.55Start price

$146.12Current

+26,242.2%Growth

+125.2%Approx. 5-year

$181.18BMarket value

1.24BShares / Tokens

HealthcareCategory

ChemicalsSector / theme

LISTEDStatus

—Exchange

—Country

GILDTicker

This period covers 1992-02-01 → 2026-08-21. First available $0.55 → Current $146.12. Log scale (long history). IPODUDE.COM research display. Not investment advice.

Campaigns

On IPODUDE.COM

IPODUDE.COM

Explore IPOs. stocks. filings. reports.

Public companies, IPO activity, and market themes.

IPODUDE.COM · Business directory, IPOs, stocks, filings Browse directory →

Auto-rotates. Use arrows anytime.

Recent Filings

CIK	Form	Date	Brief Summary	SEC
0000882095	No recent filings listed for this company.			—

Informational only. Not investment advice. Market data may be delayed or incomplete.

About

is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.

Directory · Stocks · Reports

$ investment (illustrative)

Illustrative 2034: $207.80 · +42.2% from current

	Current	Future
Year
Stock price
Worth ($)

Educational model only. Illustrative, not a prediction or investment advice.

If you invested

Enter an amount to see an illustrative value from the research path start to current.

	Then	Now
Amount
Path growth

Educational illustration from first available research price to current research price. Not a prediction or investment advice. Past path is not future performance.

IPODUDE.COM